Primary contact sensitization site. A determinant for the localization of a diphenhydramine eruption.
D000284:Administration, Oral; D000328:Adult; D011040:Dermatitis, Toxicodendron / Q000188:drug therapy; D004155:Diphenhydramine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D003875:Drug Eruptions / Q000209:etiology*; D004342:Drug Hypersensitivity / Q000209:etiology*; D005260:Female; D005542:Forearm; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000139:chemically induced*; D012882:Skin Tests
D004155:Diphenhydramine